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Based on its developmental pattern of expression, early studies suggested the implication
of the mammalian Prion protein PrP, a glycosylphosphatidylinositol-anchored ubiquitously
expressed and evolutionary conserved glycoprotein encoded by the Prnp gene, in early
embryogenesis. However, gene invalidation in several species did not result in obvious
developmental abnormalities and it was only recently that it was associated in mice with
intra-uterine growth retardation and placental dysfunction. A proposed explanation for this
lack of easily detectable developmental-related phenotype is the existence in the genome
of one or more gene (s) able to compensate for the absence of PrP. Indeed, two other
members of the Prnp gene family have been recently described, Doppel and Shadoo, and
the consequences of their invalidation alongside that of PrP tested in mice. No embryonic
defect was observed in mice depleted for Doppel and PrP. Interestingly, the co-invalidation
of PrP and Shadoo in two independent studies led to apparently conflicting observations,
with no apparent consequences in one report and the observation of a developmental
defect of the ectoplacental cone that leads to early embryonic lethality in the other. This
short review aims at summarizing these recent, apparently conflicting data highlighting
the related biological questions and associated implications in terms of animal and human
health.
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INTRODUCTION
Studies on the neuropathology of transmissible spongiform
encephalopathy (TSE) revealed that misfolded, aggregated con-
formers of the host-encoded cellular protein PrP are the major
if not the sole constituent of the infectious agent termed prion
(Prusiner, 1982). Prion pathologies affect humans, with the
Creutzfeldt-Jakob and Kuru diseases for example, and animals,
with for instance the bovine spongiform encephalopathy and
sheep scrapie. PrP is a glycosylphosphatidylinositol-anchored,
ubiquitously expressed, glycoprotein encoded by the Prnp gene.
The PrP primary and tertiary structures are well conserved among
mammals. Although many studies focused on PrP potential role
in the central nervous system in association with prion neurotox-
icity, the evolutionary conservation of this protein and the Prnp
gene expression pattern suggested that PrP may exert important
biological roles. Numerous functions were attributed to PrP such
as its implication in various signal transductions, cell adhesion,
neuroprotection, basic biology of embryonic and tissue-specific
stem cells, T-cell regulation and immune function, oxidative
stress homeostasis and synaptic function (Westergard et al., 2007;
Linden et al., 2008; Zomosa-Signoret et al., 2008; Haigh et al.,
2010; Resenberger et al., 2011; Schneider et al., 2011; Lopes and
Santos, 2012, for recent reviews as well as associated reviews
from this special issue). However, the precise PrP biological role
remains rather elusive. It may relate to the multiplicity of partners
with which PrP appears to interact, with noticeable differences
according to the cell type considered and/or the physiological
condition assessed. These diverse cellular proteins include trans-
membrane receptors, metal ion transporters, signaling molecules,
cytoskeleton-associated proteins which could suggest that PrP is
a key component of a versatile signaling scaffold complex that
allows the activation of various biological pathways.
One further difficulty in understanding PrP physiological
function relates to the lack of obvious phenotype in Prnp-
knockout mice, apart from resistance to TSE and the disappear-
ance of the neurotoxicity associated with prions (Büeler et al.,
1992, 1993; Manson et al., 1994). This absence of a strong pheno-
type could have various, non-mutually exclusive, origins such as
(i) the lack of a crucial function of this protein in non-challenging
breeding conditions, (ii) genetic adaptation of the animals to the
lack of this protein, (iii) biological functional redundancy with
other host-encoded proteins able to take over at least some of the
PrP roles, and (iv) genetic robustness with PrP being involved in
biological functions for which several pathways naturally exist. As
mentioned above, the evolutionary conservation of the PrP pro-
tein during evolution, at least in mammals, and its involvement
in the homeostasis of various stem cells appear somehow con-
tradictory with an absence of important function(s). However,
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such function could be crucial only to allow adaptation of the
animal against stressful conditions, situations that have not been
yet really tested, or only in a few occasions, for Prnp-knockout
mice. The second hypothesis has been challenged by the obser-
vation that invalidation only in adult neurons of the Prnp locus
did not induce histopathological changes but resulted in a mod-
ulation of neuronal excitability (Mallucci et al., 2002), with very
limited associated transcriptional alteration at a global brain level
(Chadi et al., 2010). However, despite its high level of expression
in the adult nervous system, PrP biological role might be crucial at
earlier developmental stages in this and/or other tissues of the ani-
mal. Two other members of the prion gene family, that share with
PrP some structural features (Figure 1), were recently described
in the mammalian genomes, Prnd which encodes Doppel and
Sprn which encodes Shadoo. These three genes are supposedly
evolutionary derived from the retro-insertion event of a gene
belonging to one of the four subfamilies of the Zinc trans-
porter containing protein-encoding genes, the ZIP LIV-1 branch
(Schmitt-Ulms et al., 2009; Ehsani et al., 2011). The existence
of these two related proteins could be seen as being in favor of
the existence of a biological redundant mechanism. Investigations
toward testing this hypothesis led to apparently contradictory
observations that have yet to be conciliated (Young et al., 2009;
Daude et al., 2012; Passet et al., 2012).
Besides the understanding of the precise mechanism leading
to the lack of strong phenotypes in Prnp-knockout mammals,
a related and yet unsolved question is the tissue where and the
developmental stage at which this phenotype would be the more
likely to occur. Because of its involvement in TSE and of its higher
level of expression in the adult nervous system, many studies first
focused on this tissue. However, accumulating evidences asso-
ciate PrP with stem cell biology and early developmental and
regenerative processes. Of specific interest is thus the potential
involvement of these proteins in the regulation of the extra-
embryonic annexes and more precisely the placenta, based on the
observation of the developmental regulation of this gene family
in such normal or pathological tissues and on the association of
alleles, including experimental gene knockouts, with phenotypes
involving or at least recalling placental functional failures. This
review summarizes our current knowledge on this specific topic.
PRION PROTEIN GENE FAMILY EXPRESSION IN
EXTRA-EMBRYONIC TISSUES
Available data on the regulation of the prion protein gene family
in extra-embryonic tissues are limited and mostly related to the
Prnp gene. Both in situ hybridization (Manson et al., 1992; Alfaidy
et al., 2013) and uses of a Prnp-promoter/LacZ reporter trans-
gene (Tremblay et al., 2007) allowed to identify mouse Prnp-gene
expression in extra-embryonic membranes as early as 6.5 days
post-coïtum, E6.5, the earliest analyzed developmental stage in
these studies. This stage corresponds to a transition toward oxida-
tive metabolism and is associated with an increase of the Prnp
gene expression level (Miele et al., 2003). A similar early extra-
embryonic expression of Prnp was reported in human (Donadio
et al., 2007), rat (Tanji et al., 1995), and ruminant (Kubosaki et al.,
2000; O’Rourke et al., 2011) placentas. However, this gene devel-
opmental regulation might differ between species, as observed for
example in human where the high level of Prnp expression was
restricted to the first trimester of pregnancy.
Transcription of members of the prion protein gene family
was also detected at earlier developmental stages (Table 1). Mouse
embryonic stem cells were reported to express the three genes
(Miranda et al., 2011) and human embryonic stem cells to express
at least the Prnp one (Krejciova et al., 2011; Lee and Baskakov,
2013). Prnp gene expression was also observed in human tro-
phoblast cells (Alfaidy et al., 2013) and that of Sprn indirectly
suspected to occur in mouse trophectoderm (Passet et al., 2012).
We have detected Sprn and Prnd gene expressions in extra-
embryonic tissues of mouse embryos at E10.5 and E13.5 (our
unpublished observation and Young et al., 2011). In sheep, Prnp
FIGURE 1 | Schematic representation of PrP, Shadoo and Doppel mature
proteins. Representations are not at scale. Light blue boxes: N-terminal
charged regions of the mature proteins. α, α-helices; β, β-strands; CHO,
N-glycosylation sites. GPI glycosylphosphatidylinositol. The PrP octa-repeat
region and the Shadoo basic repeat region are indicated as well as the two
protein hydrophobic domains.
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Table 1 | Summary on prion protein family expression in placenta and
knockout phenotypes.
Gene
(Protein)
Expression in
embryonic
stem cells
Expression
in placenta
Placental and related
phenotype in knockout
mice
Prnp (PrP) Published Published Fetal and post-natal
growth retardation.
Placental abnormalities
(weight, structure).
Transcriptomic
alterations. (Khalifé et al.,
2011; Alfaidy et al., 2013)
Sprn
(Shadoo)
Published Published Post-natal growth
retardation (Daude et al.,
2012).
Transcriptomic alterations
to be confirmed
(knockdown experiments
only, Passet et al., 2012)
Prnd
(Doppel)
Published Our
observation
No described effect but
no reported specific
analysis.
Data on gene expression analyses are derived from various sources, origin of
which can be found in the article.
transcripts were also detected in mature and immature oocytes
and at the morula stage (Thumdee et al., 2007) while in mouse,
the recent sequencing of single oocytes revealed that the three
genes are potentially expressed at very low amounts in such cells
(Reich et al., 2012).
Overall, these studies suggest that in most mammalian species,
the prion family genes are transcribed very early in embryoge-
nesis, in totipotent cells, and that this expression remains both
in embryonic and extra-embryonic tissues at early differentiation
stages (Table 1). At later developmental times, more restricted
and cell-specific expression patterns have been reported, but
only few studies focused on these loci. Nevertheless, these obser-
vations suggest a potential involvement of this gene family in
early mammalian developmental stages and highlight its potential
implication in the differentiation of the extra-embryonic tissues.
POTENTIAL INCIDENCE OF SINGLE PRION PROTEIN FAMILY
GENE ON PLACENTA
THE Prnp LOCUS
In sheep, PrP variants are strongly associated with differences
in animal susceptibility to prion. The observation that some of
these PrP variants confer a stronger resistance of the animal to
some prion strains resulted in selection breeding strategies aiming
at reducing the prevalence of the disease in the sheep popu-
lation through the selection of so-called resistant Prnp alleles,
such as ARR vs. VRQ at codons 136, 154, and 171, respectively
(Clouscard et al., 1995; Jeffrey et al., 2014). While selecting ARR
animals seems efficient against scrapie development, it could have
negative consequences should Prnp or closely related genes be
involved in important economical traits, since it would force the
breeder not to consider selecting for interesting traits if they are
associated to a sensitive (VRQ) genotype. Indeed, several articles
described a potential association between the Prnp genotype and
specific traits such as lamb birth weight (Sawalha et al., 2007b)
and (post-natal) survival (Sawalha et al., 2007a; Gubbins et al.,
2009). Although these are complex traits with several potential
origins, a correlation between these observations and a role of PrP
during placentation/early development could be suspected.
Potential implication of PrP in the placental physiology was
also suggested by the observation of the deregulation of its gene
expression in pathological situations. In human, one of the most
studied albeit still mysterious gestational disease is preeclampsia.
Preeclampsia is characterized by a de novo gestational hyper-
tension and proteinuria. It is a major source of maternal and
neonatal morbidity and mortality (Sibai et al., 2005). In one third
of the cases, preeclampsia is accompanied with Intra-Uterine
Growth Restriction (IUGR), a disease where the fetus fails to
reach its genetic growth potential, often through placental dys-
function. Oxidative stress is associated with preeclampsia (Shaker
and Sadik, 2013) and abnormal placenta levels of zinc and cop-
per with preterm gestations and IUGR both in humans (Zadrozna
et al., 2009; Uriu-Adams and Keen, 2010; Kambe et al., 2014) and
mouse (Andrews et al., 2004; Tian et al., 2014). Placental tissues
deriving from preeclamptic pregnancies were found to over-
express both the Prnp genemRNA and the PrP protein (Nishizawa
et al., 2007; Hwang et al., 2010). However, this over-expression
was not equally distributed within the tissue and appeared to be
restricted to the syncytiotrophoblast (the external layer of the pla-
cental villi) and to the cytotrophoblasts (the layer of cells that
underline the syncytiotrophoblast). Both in human (Bilodeau,
2014) and in a recently published preeclamptic mouse model
(Doridot et al., 2013, 2014), strong links between preeclamp-
sia and oxidative stress were described. The octapeptide region
and adjacent sites, around histidines 96 and 111, of the PrP pro-
tein localized in its amino-terminal region bind several divalent
metals (Jackson et al., 2001; Kramer et al., 2001; Walter et al.,
2009). This ability has been associated with putative PrP func-
tions in the binding and internalizations of ions, ferrireductase
and superoxide dismutase-like activities, signal transduction and
protection against oxidative stress (Brown et al., 2001; Choi et al.,
2007; Bertuchi et al., 2012; Watt et al., 2012; Singh et al., 2013).
Concurrently, a recent study by Alfaidy et al. depicted an involve-
ment of PrP in the response to oxidative stress in the placenta
(Alfaidy et al., 2013). It was thus hypothesized that these increased
protein and mRNA PrP levels could be part of a compensatory
mechanism induced by a preeclamptic status. However, beside
this protective function, PrP could also play an active role in
the establishment of preeclampsia as signaling pathways involving
PrP have been proposed to participate or to worsen this dis-
ease. The TGFβ pathway, modulated by the prion protein (Wurm
and Wechselberger, 2006), is suspected to contribute to the
preeclamptic etiopathology (Stanczuk et al., 2007; Feizollahzadeh
et al., 2012; Ozkan et al., 2013), possibly by altering Treg cells
equilibrium (Laresgoiti-Servitje et al., 2010; Robertson et al.,
2013). Alteration of the Notch-signaling pathway leads to a defect
of trophoblast invasion that contributes to the pathogenesis of
preeclampsia (Hunkapiller et al., 2011). Interestingly, invalida-
tion of the PrP appears to modulate the placental Notch signaling
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pathway through alteration of the expression of the Jagged1 ligand
(SMR et al., unpublished observation). Thus, PrP could coordi-
nate various signal pathways in response to an oxidative stress that
lead to the development of preeclampsia.
Another indirect evidence of PrP implication in placenta-
tion came from comparative transcriptomic studies of E6.5 and
E7.5 FVB/N and FVB/N Prnp−/− embryos (Khalifé et al., 2011).
These data revealed that in Prnp gene-invalidated embryos several
major metabolic pathways such as angiogenesis, cell proliferation,
adhesion and movement were affected at these early developmen-
tal stages. Such pathways are important in placental physiology.
Furthermore, some of the identified deregulated genes were pre-
viously described as key actors of mammalian placentation, such
as Adam12 (Huppertz et al., 2006) and activin receptors (Munir
et al., 2004).
A direct implication of PrP in regulating placental function
and pregnancy outcomes was recently documented (Alfaidy et al.,
2013). This study comparatively analyzed the reproductive per-
formances of transgenic mice either over-expressing mouse PrP
(Tga20) or knockout for Prnp (Prnp−/−) with those of their wild
type (WT) counterpart. The litter size was decreased in Tga20
comparatively to that of Prnp−/− or WT mice. At E17.5, the
fetal and placental weights of the Prnp−/− mice were lower than
that of the two other genotypes and in their adulthood, both the
Prnp−/− and Tga20 mice had lower body weights compared to
their WT counterparts. This study further highlighted a role of
PrP in placental Cu homeostasis and protection against oxida-
tive stress as well as its involvement in placental angiogenesis,
two of the altered metabolic pathways identified in the above-
mentioned embryonic transcriptomic study (Khalifé et al., 2011).
Phenotypic analysis of Prnp−/− mice revealed a compacted pla-
cental labyrinth structure and a disorganization of the vascular
tree, disorganization also observed in Tga20 placentas. Alteration
of the expression of genes specific of spongiotrophoblasts, inva-
sive trophoblasts or related to the labyrinth branching were
noticed. Trophoblastic cell mobility is an important physiolog-
ical process that allows placental cells to invade uterine tissue,
contributing to the anchorage of the placenta, to the regulation
of decidual angiogenesis and to the remodeling of the maternal
spiral arteries. This mechanism is complex and involves differ-
ent cell types and signaling pathways (Gasperowicz and Otto,
2008; Knofler, 2010, for recent reviews). PrPmight also be directly
involved in angiogenesis (Turu et al., 2008) and hematopoiesis
(Palmqvist et al., 2007). This might be related to its localization
in caveolae and interaction with Caveolin-1, known to be involved
in angiogenesis (Griffoni et al., 2000; Massimino et al., 2002).
Overall these studies highlighted a role of PrP during placen-
tation. Deregulation of the expression of the gene and differences
in PrP genotypes were associated with placental perturbations
(Table 1). However, these events did not result in overt pheno-
types, suggesting either that PrP function in this tissue is not
crucial enough for its development to induce embryonic distress
or that compensatory mechanisms exist.
THE Prnd AND Sprn LOCI
The Prnd gene has been invalidated in two different mouse
genetic backgrounds, 129/Ola (Paisley et al., 2004) and a mixed
C57BL6/CBA one (Behrens et al., 2002). In both experiments,
knockout males suffered from severe subfertility involving a
defect in acrosome biogenesis. These males also suffered from
other sperm abnormalities that varied between the two reports
probably in relation with the different genetic background.
Because of this male phenotype, a knockout transgenic line could
not be propagated by classical breeding and homozygous knock-
out animals were only routinely obtained using heterozygous
males. In both articles, reproduction of the knockout females
were reported to be normal in terms of fertility and litter sizes.
Although not specifically studied, none of these reports described
other associated phenotypes, suggesting either that Doppel has
no role during early embryogenesis or that, should it be involved
in placentation, its gene invalidation does not induce drastic
alterations (Table 1). However, as Doppel is expressed in mouse
extra-embryonic tissues (our unpublished observation), more
dedicated analyses should probably be conducted before formally
excluding it from the list of proteins involved in the physiology
of the placenta. The α-helical region of the Doppel protein binds
copper (Qin et al., 2003), but this interaction does not appear
to induce the protein internalization, as it is observed for PrP
(Cereghetti et al., 2004). It was also reported that Doppel expres-
sion might exacerbate oxidative damage (Wong et al., 2001), but
this property is discussed (Qin et al., 2003). Thus, analysis of a
putative role of Doppel in oxidative stress homeostasis during
placental development would be worth looking at.
The Sprn gene invalidation was also recently obtained
by homologous recombination in 129Pas ES cells (Daude
et al., 2012). These cells were used to derive C57BL/129 and
FVB/NCr/129 Sprn−/− mice that were reported to have no gross
morphological alterations and to be fertile (Daude et al., 2012).
However, 8–16 days old knockout females from the first genetic
backgroundwere found to have slightly lighter body weights com-
pared to their wild-type counterparts, while knockout males of
both genetic backgrounds had a similar weight phenotype at older
ages, from day 28 till 42 for C57BL/129 and from day 22 to 50
for FVB/NCr/129 Sprn−/− mice, respectively. Overall this subtle
alteration resulted in a weight decrement of about 9%. In a fol-
lowing up review, the authors suggested that the origin of this
phenotype could be related to the natural expression of Shadoo
in hypothalamic neurons, a structure associated with the control
of feeding behavior (Daude and Westaway, 2012). Several other
explanations could also be proposed. Amammary defect resulting
in modified lactation ability of the knockout females would also
induce growth retardations; however such a phenotype would
probably affect all pups similarly. Interestingly, uteroplacental
insufficiency and altered maternal nutrition during gestation
have also been associated with sex-specific post-natal develop-
ment defects of rat offsprings (Howie et al., 2012; Wadley et al.,
2013). It could thus be also hypothesized that the body weight
phenotype described for the Sprn−/− pups arises from a defect
in the placentation process. In line with this suggestion is the
observation that the mean litter size of these Sprn−/− females
is smaller than that of their Sprn+/− counterparts (Table S1
in Daude et al., 2012). Transcriptomic analyses performed on
FVB/N Sprn-knockdown embryos at E6.5 and E7.5 also revealed
the differential expression of around 60 transcripts associated
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with cellular movement and development and with differentia-
tion of the hematological system. Interestingly, some of them,
such as the prolactin-related genes, pointed to a transcriptomic
deregulation affecting precisely the trophectoderm-derived com-
partment (Passet et al., 2012, 2013). Regulation of cellular metal
uptake by PrP is probably regulated through the interaction of
this protein with other membrane-bound partners such as the
lipoprotein-receptor-related protein LRP1 (Taylor and Hooper,
2007) or the glutamate receptor AMPA (Watt et al., 2012) and,
as already discussed, this function was shown to be important for
placentation (Alfaidy et al., 2013). Although not known to bind
divalent metals, Shadoo might also indirectly regulate oxidative
stress homeostasis regulatory processes through interaction with
PrP and/or other proteins from their shared interactome (Watts
et al., 2009). This hypothesis has yet to be substantiated by experi-
mental evidences. Overall, these observations are compatible with
a gene dosage effect of Sprn expression on the ectoplacental cone
differentiation and of a potential incidence of the genetic back-
ground on the resulting phenotype, as already mentioned for
Prnd (Table 1).
CO-INVALIDATION OF SEVERAL MEMBERS OF THE PRION
PROTEIN GENE FAMILY
As alreadymentioned, the absence of a strong phenotype inmam-
mals invalidated for a single member of the prion protein gene
family has led to the hypothesis of the existence of a biological
functional redundancy with another host-encoded protein. This
model was first developed for the implication of PrP in the cen-
tral nervous system (Shmerling et al., 1998). Such proteins should
share with PrP an overlapping pattern of expression, at least at
some developmental time points, and related biological prop-
erties. The two PrP related proteins, Shadoo and Doppel, were
suspected to play this role.
Prnd AND Prnp CO-INVALIDATION
Doppel is unlikely to compensate for the lack of PrP based on
its adult pattern of expression, mainly restricted to non-nervous
tissues and the male gonads, and on its biological properties
in terms of neurotoxicity. Indeed, induced ectopic activation of
the Prnd gene expression in the adult nervous system of some
Prnp-knockout mice was shown to be neurotoxic (Moore et al.,
1999, 2001; Rossi et al., 2001; Anderson et al., 2004) and antag-
onized by full length PrP expression (Yamaguchi et al., 2004).
However, because Doppel and PrP are both expressed during
embryogenesis, it remained possible that these two proteins share
crucial properties at earlier developmental stages. To investi-
gate a potential compensation by Doppel for the absence of
PrP, both loci were co-invalidated in ES cells, taking advantage
of their physical close linkage (Paisley et al., 2004). The result-
ing animals were reported to develop normally into adulthood
with no overt phenotype beside an infertility syndrome in the
double-knockout males indistinguishable from that observed in
their single Prnd-knockout counterparts. Thus, this experiment
strongly suggests that Doppel and PrP share no obvious com-
pensatory mechanisms. The reproductive performances of these
mice, apart that of the males, were however not specifically
assessed.
Sprn AND Prnp CO-INVALIDATION
The co-invalidation of Sprn and Prnp was achieved using trans-
genic lines derived from targeted 129Sv/Pas ES cells. Double
knockout animals were obtained by crossing Sprn−/− with
FVB.129-Prnp−/− mice (Daude et al., 2012). The resulting mice
were viable, fertile and produced at expected Mendelian ratios.
No overt phenotype was reported, even in aged individuals, and
the above-discussed lighter body-weight of the single Sprn−/−
mice not mentioned in these animals (Daude et al., 2012).
Altogether, this work strongly argued against compensation or
redundancy between Shadoo and PrP in the adult nervous system
and during embryogenesis (Daude and Westaway, 2012).
However, this conclusion drastically contrasts with previous
experiments aimed at lowering the expression of the Sprn gene in
various genetic backgrounds by RNA interference, RNAi (Young
et al., 2009; Passet et al., 2012). Indeed, using lentiviral ShRNA-
delivery in mouse embryos, Sprn gene knockdown resulted in
early embryonic lethality, between E8 and E11, in an FVB/N.129-
Prnp−/− genetic background that was not observed in FVB/N
mice (Young et al., 2009). This lethality was associated with a
developmental defect of the ectoplacental cone and with impor-
tant hemorrhage surrounding the embryos (Passet et al., 2012).
The restriction of the lentiviral infection to the trophoblastic cell
lineage resulted in a similar lethal phenotype (Passet et al., 2012).
Consistently, embryos invalidated for Prnp and/or knockdown for
Sprn (Khalifé et al., 2011; Passet et al., 2013) display alterations
of the expression of genes involved in placental angiogenesis,
such as angiopoietin genes (Geva et al., 2005), cathepsins (Screen
et al., 2008) and matrix metalloproteinases (Fontana et al., 2012).
It would be of interest to assess in which extent, inactivation
of Shadoo and co-inactivation with PrP affects Notch signaling
in regards of PrP invalidation alone and consistently with the
crucial role of this pathway for mouse placental fetal angiogen-
esis and proper trophoblast cell type specification (Gasperowicz
and Otto, 2008). PrP expression is positively regulated by MEK
and p38 MAPK kinases (Wang et al., 2005) and it is noteworthy
that Mek-1 deficient mice die at early embryonic stages, around
E10.5, from an angiogenesis defect of the placenta (Giroux et al.,
1999). This age is reminiscent of that of the lethality occurring
in Prnp−/−Sprn-knockdown embryos (Young et al., 2009) and
it would be of interest to also assess the effect of Mek-1 on the
transcriptional regulation of Sprn in a regular context and in the
absence of PrP.
It remains that this RNAi strategy yielded seemingly con-
tradictory result compared to the classical knockout approach.
Several explanations were proposed to conciliate these observa-
tions (Daude and Westaway, 2012; Passet et al., 2013). It was
suggested that the RNAi approach may induce a potential arti-
fact resulting from either an off target effect of the two used
shRNA only phenotypically visible in Prnp-knockout embryos
or a toxicity associated with an shRNA over expression in sin-
gle Prnp or double Prnp/Sprn knockout genotypes, linked to
the role of PrP and potentially Shadoo in the regulation of the
RISC complex (Gibbings et al., 2012). Alternative hypotheses may
also be proposed, such as a higher susceptibility of the double
knockout genotype to external stresses, such as lentiviral infec-
tion. Furthermore, even if the knockdown of a gene can result
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in phenotypic outcomes comparable to that of the knockout
(De Souza et al., 2006), haplo-insufficiency may on the oppo-
site induce stronger phenotypes than the complete gene loss, as
described for Dicer1, a key regulator of microRNA biogenesis
(Lambertz et al., 2010).
The use of different genetic backgrounds is also known to
greatly influence the phenotype of genetically engineered mouse
(Doetschman, 2009). Although cautions were taken in that
respect in the knockout experiments (see comments in Daude
and Westaway, 2012), this strategy involves inbreeding crosses
over several generations. Doing so, starting from different genetic
backgrounds [129Pas for the ES cells, C57BL6 for the first estab-
lished knockout line that was then backcrossed in FVB/NCr
(Daude et al., 2012)], a selection process might take place that
progressively eliminates unfavorable allelic combinations. This
could also lead to potential miss-association between (absence
of) a phenotype and the targeted gene, as recently exemplified in
the case of PrP where abnormalities suspected to result from this
gene invalidation actually originated from co-segregating 129Sv-
derived loci (Nuvolone et al., 2013; Striebel et al., 2013). Such a
mechanism will not occur using an RNAi approach, potentially
leading to stronger associated phenotypes. One way to avoid these
potential artifacts would be to use the new custom-designed DNA
scissors to invalidate these loci in pure genetic backgrounds (Gaj
et al., 2013).
On this basis, we have engineered Sprn knockout mice through
the use of the Zinc Finger Nuclease (ZFN) technology. Our
preliminary results indicate that, as reported by Daude et al.
(2012), FVB/N Sprn−/− and FVB/N.129 Prnp−/−/Sprn−/− mice
are viable. However, these transgenic mice suffer from various
defects that are under scrutiny. In both cases, pups exhibit a
growth retardation that can be attributed, for part of it, to a mam-
mary defect of the knockout females, probably associated with
Sprn invalidation. The FVB/N.129 Prnp−/−/Sprn−/− mice are
also characterized by increased embryonic and perinatal lethal-
ity rates compared to FVB/N or FVB/N.129 Prnp−/− controls,
the extent of which is under analysis. Finally, some phenotypic
differences in the survival of the mice at the past weaning stage
between FVB/N Sprn−/− and FVB/N.129 Prnp−/−/Sprn−/− mice
appear to result from the 129 genetic contribution in the double
knockout mice. Altogether, these preliminary and unpublished
observations are consistent with a role of these two related pro-
teins in placentation. They further reassert the importance of the
influence of the genetic background and suggest the contribution
of other yet unknown loci in the phenotypic consequences of the
Prnp and Sprn invalidations.
A remaining issue concerns the discrepancy observed between
the knockout and the knockdown experiments. We could exclude
a specific susceptibility of the FVB/N.129 Prnp−/−/Sprn−/− mice
toward lentiviral infection per se. Three other hypothesis are
currently tested: (i) an impact of ShRNA over-expression in
FVB/N.129 Prnp−/−/Sprn−/− embryos in relation with a poten-
tial function of these proteins in miRNA regulation, (ii) an off-
target effect of the anti-Sprn ShRNAs used in Young et al. (2009)
that would down-regulate the expression of a protein leading to a
detrimental effect on the development of the ecoplacental cone in
FVB/N.129 Prnp−/− and/or FVB/N.129 Prnp−/−/Sprn−/− mice
or (iii) a genetic adaptation of the double-knockout embryos
to the lack of these two proteins highlighting other loci able
to compensate for the lack of them. Pursuing this analysis will
thus undoubtedly increase our knowledge on early mammalian
embryogenesis.
SIMILARITIES OF THE SIGNALING PATHWAYS ASSOCIATED
WITH THE PRION PROTEIN FAMILY IN PLACENTATION AND
IN ZEBRAFISH EARLY EMBRYOGENESIS
As mentioned before, the biological roles of the PrP, of the
related Shadoo and to a lesser extend of the Doppel proteins
still remain elusive in mammals. Investigations on the PrP bio-
logical role were also performed on more distantly species such
as Zebrafish. Again, the outcome of these studies surprisingly
differed according to the experimental approaches used, mor-
pholinos or knockout, somehow recalling the situation described
in mouse. Morpholino-induced downregulation of PrP1 or PrP2
resulted in high mortality of the depleted early embryos. Lethality
occurred at developmental stages related to the respective two
genes’ spatio-temporal patterns of expression, and was associated
with deficient morphogenic cell movements and induced apop-
totic cell death (Malaga-Trillo et al., 2009; Nourizadeh-Lillabadi
et al., 2010). Surviving PrP2- (Nourizadeh-Lillabadi et al., 2010)
or PrP1- (Kaiser et al., 2012) depleted embryos also highlighted a
neuroprotective role of these proteins. In contrast to PrP-2 mor-
pholino experiments, the knockout of this gene by a ZFN-based
approach resulted in no overt developmental phenotypes (Fleisch
et al., 2013). This apparent discrepancy was attributed in part to
an off target effect of the used morpholinos. In contrast, PrP1-
knockdown by morpholinos can be considered as specific as the
phenotype can be partially rescued by the injection of PrP1 or
PrP2 mRNA.
Interestingly, the function of PrP1 in early embryonic devel-
opment of the Zebrafish could be partly rescued in depleted
embryos by the injection of mammalian PrP-encoding mRNAs,
suggesting evolutionary conservation of some of the protein func-
tions (Chiesa and Harris, 2009; Malaga-Trillo and Sempou, 2009;
Malaga-Trillo et al., 2009; Solis et al., 2013). Besides, in mouse
Prnp−/− embryos, transcriptomic analyses revealed similarities
with PrP1-depleted Zebrafish eggs by highlighting the over-
expression of genes encoding proteins with proteolysis activities
that could modulate cellular adhesion and proliferation as well as
extracellular matrix deposition (Khalifé et al., 2011). The same
pathways were also deregulated in Shadoo-depleted embryos,
suggesting that this protein shares some of these PrP-functions
at least in mammals (Passet et al., 2012). In Zebrafish, the PrP1-
depleted phenotype is associated with an abnormal intracellular
processing and/or transport of E-cadherin, potentially resulting
from a modulation of the Fyn signaling pathway (Malaga-Trillo
et al., 2009). Similarly in mammals, PrP has been linked to the
activation of Src kinases, including Fyn (Mouillet-Richard et al.,
2000), while in early mouse embryos, both Prnp and Sprn down-
regulations induced protocadherin and cadherin transcriptomic
alterations (Khalifé et al., 2011; Passet et al., 2012). In mouse
embryos, the trophectoderm is the first differentiated tissue to
form, with cells requiring complex adhesive structures and inva-
sive capacities. Migrating trophoblast cells are first observed at
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E6.5 (Croy et al., 2012). Thus, the alterations of cell adhesion
pathways in Sprn and Prnp invalidated mice, similar to the alter-
ations exhibited by PrP1-depleted zebrafish, are very likely to
affect this specialized tissue at these early embryonic stages.
CONCLUSION—ONGOING OR POTENTIAL FUTURE
DIRECTIONS
Current data clearly indicate that the PrP protein has an impor-
tant role in early mammalian embryogenesis through its impli-
cation in placental physiology. The mechanistic behind these
observations has yet to be clearly deciphered and could involve
several, not mutually exclusive, processes such as an involvement
in cell adhesion and angiogenesis as well as a role in the con-
trol and response to oxidative stress. A similar implication of
Shadoo has also been suggested by several studies but whether
this protein acts through identical, complementary or unrelated
biological pathways with those of PrP remains a debatable ques-
tion. The properties of Doppel and its pattern of expression make
it an interesting potential partner, but no evidence so far has
pointed to this protein as being a key actor of placental physi-
ology. Taking into account the phenotypes observed through the
modulation of the expression of these genes in placenta and the
affected pathways, the knowledge accumulated on the function
of these proteins in this tissue could be of particular interest in
regards with their more and more recognized implication in can-
cers. A crosstalk between these so far independent studies would
be of great interest with potential benefits for human and animal
health.
A yet poorly investigated question is the relation between these
proteins and the biology of mitochondria. PrP depletion was
shown to result in reduced mitochondrial numbers and unusual
mitochondrial morphology with increased diameters and poorly
defined and sparse cristae in several mouse tissues (Miele et al.,
2002). PrP depletion induced elevated mitochondrial manganese
superoxide dismutase activity, manganese-induced mitochon-
drial depolarization and reactive oxygen species generation.
Brains of Prion-infected mice have reduced cytochrome C oxi-
dase and manganese superoxide dismutase activities and contain
swelling mitochondria. Oxidative stress conditions can induce
PrP localization in raft-like microdomains of the mitochon-
dria membranes, resulting in loss of this membrane potential.
Impairedmitochondrial function is associated with perturbations
of mouse placental (Wakefield et al., 2011) and potentially with
preeclampsia (Shi et al., 2013; Doridot et al., 2014) developments.
Thus, it is tempting to suggest that oxidative stress conditions and
preeclampsia through its induced over-expression of PrP, might
trigger the delocalization of some PrP proteins in sub-domains
of the mitochondria membrane resulting in induced mitochon-
dria dysfunctions and placentation defects. Similar implication of
the other prion protein family members is a yet-to-be explored
direction for future experimentations.
One difficulty to delineate the role of these proteins might
be related with their mode of action. As nicely highlighted by
Alfaidy et al. (2013), these proteins may act as gatekeeper of cel-
lular integrity and thus, in the absence of specific insults such as
oxidative stress conditions, their absence might not yield strong
phenotypes. Challenging through diverse approaches the existing
panel of created animal models with altered expression of these
genes would reveal such roles.
It was also suggested that these proteins, which have diverse
and large interactomes, may participate to versatile signaling
scaffold complexes, allowing activation of various biological path-
ways. As such, one might expect this function to be revealed by
invalidation of their encoding genes unless (i) biological redun-
dancy exists, (ii) the involved biological pathways are associated
with non-essential functions or related to response to various
stress as discussed just before, (iii) their absence may be, at least
partially, compensated through selection of specific genetic envi-
ronment. This latter hypothesis is attractive as it would explain
the different outcomes of the knockout of these genes according
to the genetic background, as observed for Doppel, and/or to the
methodology used, as observed for Shadoo. It would also recon-
cile the discrepancy between in vitro data, suggesting that these
proteins have key biological functions in crucial pathways such
as stem cell homeostasis, with in vivo observations, which appear
to deny or limit their importance. The classical knockout process
involves the establishment of transgenic lines in mixed genetic
backgrounds, allowing the selection process of the less detrimen-
tal genetic combinations. New approaches now exist to assess gene
invalidation in controlled genetic backgrounds, such as the use
of endonucleases (Wijshake et al., 2014). The implementation of
this approach to target the prion gene family in different mouse
strains might help us to better understand the role of each of
these proteins and their potential biological redundancy. Such
experiments are currently ongoing and their conclusions much
awaited.
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